Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Revenues $ 0 $ 1,141,000 $ 27,056,000 $ 9,988,000
Cost of revenues 0 0 4,008,000 2,237,000
Gross profit 0 1,141,000 23,048,000 7,751,000
Research and development expense 655,000 259,000 1,142,000 364,000
Selling, general and administrative expenses 5,112,000 4,184,000 14,284,000 10,953,000
Total operating expenses 5,767,000 4,443,000 15,426,000 11,317,000
Income (loss) from operations (5,767,000) (3,302,000) 7,622,000 (3,566,000)
Other income        
Change in fair value of warrant liability 1,530,000 0 1,530,000 0
Income (loss) before income taxes (4,237,000) (3,302,000) 9,152,000 (3,566,000)
Provision for income taxes 0 0 269,000 0
Net income (loss) (4,237,000) (3,302,000) 8,883,000 (3,566,000)
Accretion of Preferred stock 0 (1,309,000) (3,925,000) (6,789,000)
Net income (loss) to common stockholders $ (4,237,000) $ (4,611,000) $ 4,958,000 $ (10,355,000)
Net income (loss) per share, basic (in dollars per share) $ (0.16) $ (0.14) $ 0.36 $ (0.16)
Net income (loss) per share, diluted (in dollars per share) (0.16) (0.14) 0.34 (0.16)
Net income (loss) per share applicable to common stockholders, basic (in dollars per share) (0.16) (0.20) 0.20 (0.45)
Net income (loss) per share applicable to common stockholders, diluted (in dollars share) $ (0.16) $ (0.20) $ 0.19 $ (0.45)
Weighted-average common shares outstanding, basic (in shares) 27,327,936 22,853,865 24,588,296 22,775,918
Weighted-average common shares outstanding, diluted (in shares) 27,327,936 22,853,865 26,138,201 22,775,918